Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 917 páginas
Examen

Katzung's Basic and Clinical Pharmacology 16th Edition Test Bank Exam Prep

Document preview thumbnail
Vista previa 4 fuera de 917 páginas

Katzung's Basic and Clinical Pharmacology 16th Edition Test Bank Exam Prep SEO Description Master pharmacology with this comprehensive chapter-by-chapter test bank for Katzung's Basic and Clinical Pharmacology, 16th Edition. Designed for nursing, pharmacy, and medical education, it features NCLEX-style and NGN-style questions, SATA items, clinical judgment exercises, medication therapy case studies, and detailed answer rationales. Strengthen understanding of drug mechanisms of action, pharmacokinetics, pharmacodynamics, pharmacogenomics, therapeutic indications, adverse drug reactions, contraindications, precautions, drug interactions, medication safety, and patient education. Coverage spans cardiovascular, autonomic, endocrine, respiratory, gastrointestinal, neurologic, psychiatric, antimicrobial, anticancer, immunologic, and toxicology pharmacology. Ideal for exam preparation, pharmacotherapy decision-making, dosage calculations, evidence-based practice, nursing implications, individualized drug therapy, and safe medication administration and monitoring. SEO Keywords Katzung's Basic and Clinical Pharmacology 16th Edition Test Bank Chapter-by-Chapter Pharmacology Exam Prep NCLEX NGN Pharmacology Practice Questions Pharmacokinetics and Pharmacodynamics Review Medication Safety and Pharmacotherapy Test Bank Nursing Pharmacology Clinical Judgment Questions Pharmacy Education Drug Therapy Exam Preparation

Vista previa del contenido

KATZUNG'S BASIC AND
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH




TEST BANK

,Question 1
A nurse is reviewing the phases of clinical drug development for
a newly approved medication. Which statement by a nursing
student indicates correct understanding of Phase III clinical
trials?
A. “The drug is tested on healthy volunteers to determine
toxicity.”
B. “The medication is compared with standard therapy in a
larger patient population.”
C. “The purpose is to monitor adverse effects after the drug is
marketed.”
D. “Animal studies are performed to evaluate teratogenic
effects.”
Correct Answer: B
Rationale:
Phase III clinical trials involve large groups of patients who have
the disease or condition being treated. These trials compare the
investigational medication with current standard therapies and
further evaluate effectiveness, safety, and adverse reactions
before approval. Option A describes Phase I trials. Option C
describes Phase IV post-marketing surveillance. Option D refers
to preclinical animal testing conducted before human studies
begin.

,Question 2
A client taking multiple prescription medications asks the nurse
why the liver is important in drug therapy. Which response by
the nurse is most accurate?
A. “The liver stores all medications permanently until they are
needed.”
B. “The liver converts many drugs into forms that can be
eliminated from the body.”
C. “The liver prevents medications from entering the
bloodstream.”
D. “The liver destroys all active drugs immediately after
absorption.”
Correct Answer: B
Rationale:
The liver plays a major role in drug metabolism by converting
medications into more water-soluble compounds that can be
excreted. This process may activate, inactivate, or alter drugs.
Option A is incorrect because drugs are not permanently stored
in the liver. Option C is incorrect because medications
commonly enter the bloodstream before hepatic metabolism.
Option D is incorrect because not all drugs are immediately
destroyed; many remain active for therapeutic benefit.

, Question 3
A nurse administers an oral opioid medication and notes that
the prescribed dose is higher than the equivalent intravenous
dose. Which pharmacokinetic principle best explains this
difference?
A. Drug tolerance
B. First-pass metabolism
C. Receptor down-regulation
D. Protein displacement
Correct Answer: B
Rationale:
First-pass metabolism occurs when orally administered drugs
pass through the liver before reaching systemic circulation,
reducing the amount of active drug available. Therefore, oral
doses may need to be higher than intravenous doses. Option A
refers to decreased response after repeated exposure. Option C
involves changes in receptor numbers. Option D relates to
competition for plasma protein binding sites.
Question 4
A client develops severe hypotension after receiving an
excessive dose of an antihypertensive medication. Which term
best describes this harmful medication effect?

Libro relacionado
 image
Editorial: 2023 ISBN: 9781260463309 Edición: Desconocido

Información del documento

Subido en
5 de julio de 2026
Número de páginas
917
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$37.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
3
Seguidores
0
Artículos
185
Última venta
4 meses hace


Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes